Plasmodium vivax aldolase-specific monoclonal antibodies and its application in clinical diagnosis of malaria infections in China

Abstract

BackgroundMost rapid diagnostic tests (RDTs) currently used for malaria diagnosis cannot distinguish the various Plasmodium infections. The development of a Plasmodium vivax specific RDTs with high sensitivity to sufficiently differentiate the two most common Plasmodium infections would be very crucial for disease treatment and control.MethodPlasmodium vivax aldolase gene (PvALDO) was amplified from the extracted genomic DNA and constructed into pET30a vector. Plasmodium vivax aldolase protein was successfully expressed in Escherichia coli in soluble form and the overall purity was over 95% after one-step affinity chromatography purification. The purified products were used for the immunization of mice and rabbits. Rabbit polyclonal antibodies generated were deployed to develop a novel antibody-capture ELISA for hybridoma screening.ResultsThree PvALDO specific mAbs (14C7, 15F1 and 5H7) with high affinities were selected and used in immunochromatographic test strips. Clinical blood samples (n=190) collected from Yunnan (China) were used for evaluation and the RDT’s sensitivity for P. vivax was 98.33% (95% Confidence Interval (CI): 91.03% to 99.72%) compared with microscopic examination. There was specificity of 99.23% (95% CI: 95.77% to 99.87%) for P. vivax. Only one Plasmodium falciparum sample was detected among the P. falciparum samples (n=20). All Plasmodium malariae samples (n=2) as well as healthy uninfected samples (n=108) were negative. Overall performance of this RDT was excellent with positive predictive value (PPV) and negative predictive value (NPV) of 98.33% and 99.23%, respectively, at 95% CI and a very good correlation with microscopic observations (kappa value, K=0.9757). Test strips show high sensitivity even at 6.25 ng/ml of recombinant P. vivax aldolase (rPvALDO).ConclusionThis study further elucidates the possibility of developing aldolase-specific RDTs which can differentiate the different Plasmodium infections and improve accurate diagnosis of malaria. This RDT could adequately differentiate between P. vivax and P. falciparum infections. The novel mAb screening method developed here could find application in the screening of highly specific antibodies against other antigens.

An Anti-proteome Nanobody Library Approach Yields a Specific Immunoassay for Trypanosoma congolense Diagnosis Targeting Glycosomal Aldolase

“…This is not the first report presenting aldolase as a specific biomarker for pathogen detection. The enzyme variant encoded by Plasmodium vivax serves as a biomarker for the diagnosis of malaria [ 53 ]. Based on the structures of aldolases encoded by T .…”

Development of a fluorescent immnunochromatographic assay for the procalcitonin detection of clinical patients in China

“…The resultant construct carrying the PCT gene was then transformed into E. coli BL21 (DE3) cells and the recombinant PCT with his tag (hrPCT-his) protein was expressed and purified using the methods described previously [19,20]. After induction with isopropyl-β-D-thiogalactopyranoside (IPTG), the cultures were harvested by centrifugation.…”

“…Mice were sacrificed and the spleen cells were fused with the myeloma cell line SP2/0-Ag14 using PEG 1500 as described previously [20]. Briefly, the fused cells were then mixed with methylcellulose-RPMI 1640 media supplemented with 15% (v/v) FBS, 100 U/ml penicillin, 100 μg/ml streptomycin, 1% (v/v) HEPES, 2% (w/v) methyl cellulose, 1% (v/v) HAT), and plated on petri dishes (35 mm).…”

Development of Monoclonal Antibodies against HIV-1 p24 Protein and Its Application in Colloidal Gold Immunochromatographic Assay for HIV-1 Detection

“…On day 38, a final injection of 50 μ g r-p24 in PBS was administered intraperitoneally. Hybridoma and mAbs were generated as described previously [ 9 ].…”